FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016056242> ?p ?o ?g. }

• W2016056242 endingPage "1290" @default.
• W2016056242 startingPage "1284" @default.
• W2016056242 abstract "Major depressive disorder (MDD) is a devastating disease that afflicts large populations and has also been accepted to be an independent risk factor for cardiovascular disease (CVD). Oxidative stress seems to play an essential role in the relationship of MDD and CVD. We aimed to determine the level of oxidative stress in patients with MDD and to investigate the effects of long-term antidepressant (AD) treatment on the oxidative-antioxidative system parameters and CVD risk factors.Fifty patients who fully met the fourth Diagnostic and Statistical Manual of Mental Disorders criteria for MDD and 44 healthy control subjects were included in the study. Control visits of the patients were repeated 6weeks, 12weeks and 24weeks after beginning of the AD treatment. Lipid profiles, oxidation and oxidizability of apolipoprotein B-containing lipoproteins (expressed as apo B-b-MDA and apo B-Δ-MDA, respectively), levels of plasma malondialdehyde (p-MDA), total antioxidative capacity (TAOC), antioxidant molecules and antioxidant enzyme activities including paraoxonase/arylesterase, red blood cell superoxide dismutase (RBC-SOD) and glutathione peroxidase were determined during 24-week of follow-up period.According to the results of the study, p-MDA, apo B-b-MDA and RBC-SOD activity were increased and arylesterase activity was decreased in MDD patients. Body mass index (BMI), vitamin A and total cholesterol levels in MDD patients increased after 24-weeks of AD treatment. RBC-SOD activity, TAOC, p-MDA and apo B-b-MDA levels were decreased; paraoxonase/arylesterase activities and apo B-Δ-MDA were increased at the end of 24th week.Oxidative stress, demonstrated in MDD patients, was partly improved during 24weeks of AD treatment. Increase in paraoxonase/arylesterase activities and decrease in p-MDA and apo B-b-MDA levels after 24weeks seem to be beneficial for reduction of CVD risk in MDD patients. However increased BMI and apo B-Δ-MDA levels are negative cardiovascular effects of long-term AD treatment." @default.
• W2016056242 created "2016-06-24" @default.
• W2016056242 creator A5029531704 @default.
• W2016056242 creator A5038577103 @default.
• W2016056242 creator A5045578879 @default.
• W2016056242 creator A5050637863 @default.
• W2016056242 creator A5056656520 @default.
• W2016056242 date "2011-07-01" @default.
• W2016056242 modified "2023-09-28" @default.
• W2016056242 title "Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study" @default.
• W2016056242 cites W1590457525 @default.
• W2016056242 cites W1953738763 @default.
• W2016056242 cites W1963585747 @default.
• W2016056242 cites W1964518436 @default.
• W2016056242 cites W1967678385 @default.
• W2016056242 cites W1970322195 @default.
• W2016056242 cites W1978514173 @default.
• W2016056242 cites W1992446914 @default.
• W2016056242 cites W1997745709 @default.
• W2016056242 cites W1998280774 @default.
• W2016056242 cites W2017749659 @default.
• W2016056242 cites W2023952233 @default.
• W2016056242 cites W2024995822 @default.
• W2016056242 cites W2028274535 @default.
• W2016056242 cites W2034665339 @default.
• W2016056242 cites W2046792512 @default.
• W2016056242 cites W2048513018 @default.
• W2016056242 cites W2057552891 @default.
• W2016056242 cites W2062447292 @default.
• W2016056242 cites W2062929425 @default.
• W2016056242 cites W2064122326 @default.
• W2016056242 cites W2069692485 @default.
• W2016056242 cites W2074602237 @default.
• W2016056242 cites W2076371251 @default.
• W2016056242 cites W2081363371 @default.
• W2016056242 cites W2085906390 @default.
• W2016056242 cites W2090999800 @default.
• W2016056242 cites W2091293050 @default.
• W2016056242 cites W2096047662 @default.
• W2016056242 cites W2096664466 @default.
• W2016056242 cites W2097745840 @default.
• W2016056242 cites W2116404316 @default.
• W2016056242 cites W2131342968 @default.
• W2016056242 cites W2142876888 @default.
• W2016056242 cites W2155108575 @default.
• W2016056242 cites W2157219711 @default.
• W2016056242 cites W2165201727 @default.
• W2016056242 cites W2166138499 @default.
• W2016056242 cites W2185792310 @default.
• W2016056242 cites W4298592957 @default.
• W2016056242 cites W72255980 @default.
• W2016056242 doi "https://doi.org/10.1016/j.pnpbp.2011.03.021" @default.
• W2016056242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21515329" @default.
• W2016056242 hasPublicationYear "2011" @default.
• W2016056242 type Work @default.
• W2016056242 sameAs 2016056242 @default.
• W2016056242 citedByCount "120" @default.
• W2016056242 countsByYear W20160562422012 @default.
• W2016056242 countsByYear W20160562422013 @default.
• W2016056242 countsByYear W20160562422014 @default.
• W2016056242 countsByYear W20160562422015 @default.
• W2016056242 countsByYear W20160562422016 @default.
• W2016056242 countsByYear W20160562422017 @default.
• W2016056242 countsByYear W20160562422018 @default.
• W2016056242 countsByYear W20160562422019 @default.
• W2016056242 countsByYear W20160562422020 @default.
• W2016056242 countsByYear W20160562422021 @default.
• W2016056242 countsByYear W20160562422022 @default.
• W2016056242 countsByYear W20160562422023 @default.
• W2016056242 crossrefType "journal-article" @default.
• W2016056242 hasAuthorship W2016056242A5029531704 @default.
• W2016056242 hasAuthorship W2016056242A5038577103 @default.
• W2016056242 hasAuthorship W2016056242A5045578879 @default.
• W2016056242 hasAuthorship W2016056242A5050637863 @default.
• W2016056242 hasAuthorship W2016056242A5056656520 @default.
• W2016056242 hasConcept C104317684 @default.
• W2016056242 hasConcept C126322002 @default.
• W2016056242 hasConcept C134018914 @default.
• W2016056242 hasConcept C135763542 @default.
• W2016056242 hasConcept C185592680 @default.
• W2016056242 hasConcept C2775838275 @default.
• W2016056242 hasConcept C2776151105 @default.
• W2016056242 hasConcept C2776509667 @default.
• W2016056242 hasConcept C2778163477 @default.
• W2016056242 hasConcept C2778401633 @default.
• W2016056242 hasConcept C2778760513 @default.
• W2016056242 hasConcept C2781389560 @default.
• W2016056242 hasConcept C37501387 @default.
• W2016056242 hasConcept C55493867 @default.
• W2016056242 hasConcept C62746215 @default.
• W2016056242 hasConcept C71924100 @default.
• W2016056242 hasConceptScore W2016056242C104317684 @default.
• W2016056242 hasConceptScore W2016056242C126322002 @default.
• W2016056242 hasConceptScore W2016056242C134018914 @default.
• W2016056242 hasConceptScore W2016056242C135763542 @default.
• W2016056242 hasConceptScore W2016056242C185592680 @default.
• W2016056242 hasConceptScore W2016056242C2775838275 @default.
• W2016056242 hasConceptScore W2016056242C2776151105 @default.

• next